share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Green Ralph Elias

SEC ·  Jun 29 08:57
Summary by Futu AI
In a recent transaction, Ralph Elias Green engaged in the sale of shares from Vivos Therapeutics, Inc. (VVOS). The action took place on June 20, 2024. However, the specific details regarding the number of shares transacted, the nature of the shares, the transaction price, and the post-transaction shareholding were not disclosed. This information is critical for investors to assess the impact of the transaction on their investment decisions.
In a recent transaction, Ralph Elias Green engaged in the sale of shares from Vivos Therapeutics, Inc. (VVOS). The action took place on June 20, 2024. However, the specific details regarding the number of shares transacted, the nature of the shares, the transaction price, and the post-transaction shareholding were not disclosed. This information is critical for investors to assess the impact of the transaction on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.